Controlling T cells via epigenetics

INSERM team proposes new autoimmune, immunodeficiency T cell targets in epigenetic pathway

An international academic team has discovered an epigenetic pathway that regulates CD4+ T cell differentiation and activity, and could yield new therapeutic targets for autoimmunity.

As drug developers seek the next generation of targeted therapies for autoimmune disease,

Read the full 370 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE